"10.1371_journal.pone.0101969","plos one","2014-07-08T00:00:00Z","Bin Li; Colin A Flaveny; Camilla Giambelli; Dennis Liang Fei; Lu Han; Brian I Hang; Feng Bai; Xin-Hai Pei; Vania Nose; Oname Burlingame; Anthony J Capobianco; Darren Orton; Ethan Lee; David J Robbins","Molecular Oncology Program, Department of Surgery, University of Miami, Miami, Florida, United States of America; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America; Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida, United States of America; Department of Pathology, Miller School of Medicine, University of Miami, Miami, Florida, United States of America; Department of Pathology, Jackson Health System, University of Miami, Miami, Florida, United States of America; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Stemsynergy Therapeutics Inc., Miami, Florida, United States of America","Conceived and designed the experiments: BL CAF DJR. Performed the experiments: BL CAF CG LH BIH. Analyzed the data: BL CAF EL DO DLF FB XHP OB VN AJC. Contributed reagents/materials/analysis tools: EL. Wrote the paper: BL CAF DJR.","DJR, AJC and EL are founders of StemSynergy Therapeutics Inc. a company commercializing WNT inhibitors, including CK1Î± agonists. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2014","07","Bin Li","BL",14,TRUE,3,5,10,3,TRUE,TRUE,FALSE,0,NA,FALSE
